Wnt-1 inhibitors belong to a distinctive class of chemical compounds that exert their effects through targeted modulation of the Wnt-1 signaling pathway. This pathway plays a crucial role in various biological processes, including embryonic development, tissue homeostasis, and cell differentiation. Wnt-1, a glycoprotein, is a key member of the Wnt family of signaling molecules and is involved in the activation of intracellular cascades that regulate gene expression. Wnt-1 signaling is tightly controlled, as its dysregulation has been associated with numerous developmental disorders and oncogenic transformations. The inhibitors designed to specifically target the Wnt-1 pathway typically exhibit a sophisticated molecular structure that enables them to interfere with various stages of the signaling cascade.
These inhibitors often operate through different mechanisms, such as binding to Wnt-1 ligands, preventing their interaction with cell surface receptors, or inhibiting downstream effectors responsible for transmitting the signal. Many of these compounds have been meticulously developed through computational modeling and structure-activity relationship studies, optimizing their binding affinity and selectivity for Wnt-1 components. This class of inhibitors represents a culmination of years of research into understanding the intricacies of Wnt-1 signaling and its significance in normal cellular processes and disease states. In summary, Wnt-1 inhibitors are a category of chemical entities tailored to modulate the Wnt-1 signaling pathway. Their molecular design is intricately linked to their ability to interfere with the cascade at different stages, ultimately influencing downstream gene expression and cellular responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
LGK974 is a small molecule inhibitor of the Wnt pathway that targets the Porcupine enzyme, which is crucial for attaching fatty acids to Wnt ligands, enabling their secretion and activity. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
IWP-2 is another Porcupine inhibitor that prevents the secretion and activity of Wnt proteins. It's being studied for its potential in inhibiting Wnt signaling in cancer cells. | ||||||
PRI-724 | 1422253-38-0 | sc-507535 | 25 mg | $260.00 | ||
PRI-724 targets the interaction between β-catenin and its coactivator CBP, aiming to inhibit Wnt-mediated gene transcription. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV939 inhibits tankyrase enzymes, promoting the degradation of β-catenin, a central player in Wnt signaling. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
This compound inhibits porcupine, blocking the secretion of Wnt ligands and interfering with Wnt signaling. | ||||||
NSC 668036 | 144678-63-7 | sc-507412 | 5 mg | $175.00 | ||
NSC668036 targets the interaction between β-catenin and its binding partner BCL9, important for β-catenin's transcriptional activity. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $135.00 | 19 | |
IWR-1 disrupts the interaction between β-catenin and TCF, preventing the transcription of Wnt target genes. | ||||||
LF3 | 664969-54-4 | sc-507526 | 10 mg | $160.00 | ||
LF3 disrupts the interaction between β-catenin and the transcriptional coactivator Pygopus, necessary for β-catenin's transcriptional activity. | ||||||
Cardamonin | 19309-14-9 | sc-293984 sc-293984A | 10 mg 50 mg | $224.00 $940.00 | ||
Found in cardamom, Cardamonin inhibits the Wnt/β-catenin pathway and shows potential as an anti-cancer agent. | ||||||
Salinomycin | 53003-10-4 | sc-253530 sc-253530C sc-253530A sc-253530B | 5 mg 10 mg 25 mg 100 mg | $162.00 $241.00 $406.00 $474.00 | 1 | |
An antibiotic, Salinomycin inhibits Wnt signaling by targeting cancer stem cells and impacting Wnt pathway-related self-renewal. | ||||||